Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC is a global pharmaceutical company supplying high-quality generic, specialty, and branded prescription medicines. The company develops and manufactures a broad portfolio of pharmaceutical products including injectables, oral generic medications, respiratory therapies, oncology treatments, and pain management solutions. Headquartered in London, UK, Hikma operates 29 manufacturing plants and R&D centers across North America, Europe, and the Middle East and North Africa (MENA) region. As a full-service contract manufacturing organization (CMO), Hikma offers specialized drug development and contract manufacturing for injectables and oral pharmaceuticals. The business supplies healthcare systems, hospitals, distributors, and pharmacy chains across international markets. Its key production plants are inspected and approved by regulatory bodies including the US FDA and European Medicines Agency (EMA). Through continuous R&D investment and commercial alliances, Hikma expands patient access to critical generic drugs and licensed specialty therapies worldwide.